Ovide (Malathion Topical) - Summary

OVIDE SUMMARY

OVIDE^®
(malathion)
LOTION, 0.5%

OVIDE Lotion contains 0.005 g of malathion per mL in a vehicle of isopropyl alcohol (78%), terpineol, dipentene, and pine needle oil. Malathion is an organophosphate agent which acts as a pediculicide by inhibiting cholinesterase activity.

OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.

OVIDE NEWS HIGHLIGHTS

Media Articles Related to Ovide (Malathion Topical)

Lipitor 80 Mg Provided Sustained Risk Reduction Of Cardiovascular Events In Patients With Heart Disease During The Five-Year TNT Trial
Source: Cardiovascular / Cardiology News From Medical News Today [2008.09.03]

Business Week Examines Practice Of Balance Billing By Medical Providers
Source: Health Insurance / Medical Insurance News From Medical News Today [2008.09.03]

Whistle-Blower Lawsuits Helped Recover At Least $9.3B From Health Care Providers Accused Of Defrauding States, Federal Government, Analysis Finds
Source: Pharma Industry / Biotech Industry News From Medical News Today [2008.09.03]

OptumHealth Provides Free Counseling Help Line For People Coping With Tropical Storm Gustav
Source: Aid / Disasters News From Medical News Today [2008.09.01]

Are You At Risk For Gum Disease? CIGNA Dental's New Online Tool Helps Provide The Answer
Source: Dentistry News From Medical News Today [2008.09.01]

more>>

Published Studies Related to Ovide (Malathion Topical)

Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. [2004.11]

A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Creme Rinse (1% permethrin) used as labeled, for the treatment of head lice. [2007.07]

Survey of permethrin and malathion resistance in human head lice populations from Denmark. [2006.05]

Decreasing malathion application time for lice treatment reduces transdermal absorption. [2005.09.14]

Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. [2001.08]

more>>

Clinical Trials Related to Ovide (Malathion Topical)

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice [Completed]

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice [Terminated]

Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? [Completed]

Abciximab in Wake-up Stroke [Terminated]

more>>